Stock Earnings

Question 1

Genscript Biotech Corp'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Genscript Biotech Corp'in toplam varlıkları $0 olup, net profit $2,961'dir.

Question 2

GNNSF'ün temel finansal oranları nelerdir?

Accepted Answer

Genscript Biotech Corp'in cari oranı 0, net kâr marjı 498.48, hisse başına satış $0.28'dir.

Question 3

Genscript Biotech Corp'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Genscript Biotech Corp largest revenue segment is Life-science Services and Products, at a revenue of 3,516,279,684 in the most earnings release.For geography, United States is the primary market for Genscript Biotech Corp, at a revenue of 2,068,502,630.

Question 4

Genscript Biotech Corp kârlı mı?

Accepted Answer

yes, son mali tablolara göre Genscript Biotech Corp'in net profit $2,961'dir.

Question 5

Genscript Biotech Corp'in herhangi bir yükümlülüğü var mı?

Accepted Answer

no, Genscript Biotech Corp'in yükümlülüğü 0'dir.

Question 6

Genscript Biotech Corp'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Genscript Biotech Corp'in toplam tedavüldeki hisse sayısı 0'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	551	594	560	625	490	390
Revenue Growth (YoY)	21%	6%	-10%	28%	26%	43%
Cost of Revenue	266	322	289	321	207	134
Gross Profit	285	272	270	304	282	255
Selling, General & Admin	97	209	191	351	303	197
Research & Development	-151	53	52	390	358	263
Operating Expenses	-51	380	109	735	804	462
Other Non Operating Income (Expenses)	-8	-4	-3	-1	0	-4
Pretax Income	34	-170	168	-431	-517	-281
Income Tax Expense	17	2	6	-3	0	0
Net Income	3,111	2,961	-95	-226	-358	-204
Net Income Growth	-1,857.99%	-3,217%	-57.99%	-37%	75%	112.99%
Shares Outstanding (Diluted)	2,154.85	2,121.28	2,109.36	2,104.12	2,039.2	1,900.78
Shares Change (YoY)	2%	1%	0%	3%	7%	2%
EPS (Diluted)	1.44	1.39	-0.04	-0.1	-0.17	-0.1
EPS Growth	-1,900%	-3,575%	-63%	-39%	63%	107%
Free Cash Flow	141	-72	-444	-323	-274	-278
Free Cash Flow Per Share	0.06	-0.03	-0.21	-0.15	-0.13	-0.14
Gross Margin	51.72%	45.79%	48.21%	48.64%	57.55%	65.38%
Operating Margin	60.98%	-18.18%	28.57%	-68.96%	-106.53%	-52.82%
Profit Margin	564.6%	498.48%	-16.96%	-36.16%	-73.06%	-52.3%
Free Cash Flow Margin	25.58%	-12.12%	-79.28%	-51.68%	-55.91%	-71.28%
EBITDA	408	-31	233	-367	-475	-174
EBITDA Margin	74.04%	-5.21%	41.6%	-58.72%	-96.93%	-44.61%
D&A For EBITDA	72	77	73	64	47	32
EBIT	336	-108	160	-431	-522	-206
EBIT Margin	60.98%	-18.18%	28.57%	-68.96%	-106.53%	-52.82%
Effective Tax Rate	50%	-1.17%	3.57%	0.69%	0%	0%

Genscript Biotech Corp (GNNSF) Price

GNNSF Stock Price Chart

GNNSF Income

Follow-Up Questions